Back to Journals » Drug Design, Development and Therapy » Volume 9 » Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
Please verify you are not a robot.
Back to Journals » Drug Design, Development and Therapy » Volume 9 » Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
Please verify you are not a robot.